Stocks edge higher on Wall Street as trade talks press ahead

U.S. stocks advanced on Wednesday, with the S&P 500 up 0.5%, the Dow 0.4%, and Nasdaq 0.8%, as Wall Street weighed ongoing trade negotiations and extended tariff deadlines from the Trump administration. Technology and communication services led gains, notably Nvidia briefly topping a $4 trillion valuation, while the 10-year Treasury yield slid to 4.34%. This market performance occurred amid anticipation of a Q2 earnings season projected for 5% S&P 500 growth, the lowest since Q4 2023, and significant corporate news including Merck's $10 billion acquisition of Verona Pharma.

Analysis

U.S. equity markets advanced, with the S&P 500 rising 0.5% and the Nasdaq climbing 0.8%, as investors reacted to an extension of a key trade tariff deadline to August 1. This reprieve has temporarily overshadowed persistent trade war concerns, allowing market focus to shift towards strong performance in the technology and communication services sectors. This was exemplified by Nvidia (NVDA), which briefly surpassed a $4 trillion market capitalization after its shares rose 1.7%, a stark contrast to its valuation at the start of 2023. Other mega-cap tech stocks including Microsoft (MSFT), Meta (META), and Alphabet (GOOGL) also posted gains over 1%. Despite the equity rally, a flight to safety was evident in the bond market, where the 10-year Treasury yield fell to 4.34%. Significant corporate actions also influenced trading, with Merck (MRK) gaining 3.1% on its $10 billion acquisition of Verona Pharma, which saw its own shares surge over 20%. Conversely, the overhang of potential tariffs remains a tangible risk, as demonstrated by President Trump's specific threats against pharmaceuticals and copper, the latter of which contributed to a 2% decline in shares of Freeport-McMoRan (FCX). The market now looks toward an earnings season where S&P 500 profit growth is forecast by FactSet to slow to 5%, the lowest rate since Q4 2023, with airlines like Delta (DAL) already signaling weakness due to consumer uncertainty over tariffs.

Key Decisions for Investors

• While the AI-driven momentum in mega-cap tech, particularly Nvidia (NVDA), continues to be a primary market driver, investors should critically assess the sustainability of these valuations given the rapid price appreciation since early 2023.
• The market's positive reaction to the tariff deadline extension may be temporary; it is prudent to monitor exposure to sectors directly in the crosshairs of future tariffs, such as industrials (e.g., FCX) and consumer-facing industries like airlines (e.g., DAL).
• Merck's acquisition of Verona signals robust M&A activity in the healthcare sector, suggesting opportunities may exist in both pharmaceutical incumbents seeking pipeline growth and smaller biotech firms with valuable assets.
• Given the forecast for the slowest S&P 500 earnings growth since Q4 2023, investors should prioritize companies demonstrating resilient demand and margin control during the upcoming reporting season, as broad index gains may mask underlying weakness.